The (18)F-PSMA-1007 PET/CT performance on metastasis status and therapy assessment in oligo-metastasis prostate cancer

OBJECTIVE: The prostate-specific membrane antigen (PSMA) PET/CT is potentially identifying patients with oligo-metastasis who would be deemed to only have localized disease in the traditional approaches. However, the best selected oligo-metastasis prostate cancer (PCa) patients most likely to benefi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhuonan, Zheng, Anqi, Li, Yunxuan, Gao, Jungang, Dong, Weixuan, Li, Yan, Duan, Xiaoyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458929/
https://www.ncbi.nlm.nih.gov/pubmed/36091136
http://dx.doi.org/10.3389/fonc.2022.935979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458929/
https://www.ncbi.nlm.nih.gov/pubmed/36091136
http://dx.doi.org/10.3389/fonc.2022.935979

Ejemplares similares